The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
Many neurodegenerative diseases present with progressive neuronal degeneration, which can lead to cognitive and motor impairment. Early screening and diagnosis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) are necessary to begin treatment before the onse...
Main Authors: | Patrycja Pawlik, Katarzyna Błochowiak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/371 |
Similar Items
-
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
by: Hala Shaheen, et al.
Published: (2020-02-01) -
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01) -
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
by: Nicholas J. Ashton, et al.
Published: (2019-12-01) -
Is Alzheimer's Disease Infectious?<br><i>Relative to the CJD Bacterial Infection Model of Neurodegeneration</i>
by: Frank O. Bastian
Published: (2015-11-01) -
Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls
by: Ali Shalash, et al.
Published: (2017-12-01)